{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:24:06Z","timestamp":1791829446441,"version":"4.3.4"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.1001\/jamacardio.2021.5881","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:07:46Z","timestamp":1644404866000},"page":"330","source":"Crossref","is-referenced-by-count":44,"title":["A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy\u2013Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"Maryam","family":"Esmaeilzadeh","sequence":"first","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila M.","family":"Urzua Fresno","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Somerset","sequence":"additional","affiliation":[{"name":"Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Shalmon","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Amir","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Center, Division of Medical Oncology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Po Steve","family":"Fan","sequence":"additional","affiliation":[{"name":"Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brezden-Masley","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babitha","family":"Thampinathan","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yobiga","family":"Thevakumaran","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibar","family":"Yared","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Scarborough Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Anne","family":"Koch","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"},{"name":"Women\u2019s College Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woo","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yip","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine and Pathobiology, University Health Network, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Marwick","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Chan","sequence":"additional","affiliation":[{"name":"Joint Department of Medical Imaging, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd J.","family":"Wintersperger","sequence":"additional","affiliation":[{"name":"Joint Department of Medical Imaging, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paaladinesh","family":"Thavendiranathan","sequence":"additional","affiliation":[{"name":"Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"},{"name":"Joint Department of Medical Imaging, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"hoi210092r1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"hoi210092r2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jcmg.2020.09.039","article-title":"Serial cardiovascular magnetic resonance strain measurements to identify cardiotoxicity in breast cancer: comparison with echocardiography.","volume":"14","author":"Houbois","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"hoi210092r3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"hoi210092r4","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ejhf.v22.9","article-title":"Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).","volume":"22","author":"Celutkiene","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"hoi210092r5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/ejhf.v22.11","article-title":"Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"hoi210092r6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.","volume":"55","author":"Cardinale","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi210092r7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"hoi210092r8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac dysfunction in the trastuzumab clinical trials experience.","volume":"20","author":"Seidman","year":"2002","journal-title":"J Clin Oncol"},{"issue":"36","key":"hoi210092r9","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"issue":"27","key":"hoi210092r10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi210092r12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","article-title":"Multiple imputation by chained equations: what is it and how does it work?","volume":"20","author":"Azur","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"issue":"4","key":"hoi210092r13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"3","key":"hoi210092r14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1198\/106186006X133933","article-title":"Unbiased recursive partitioning: a conditional inference framework.","volume":"15","author":"Hothorn","year":"2012","journal-title":"J Comput Graph Stat."},{"issue":"1","key":"hoi210092r15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures.","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"1","key":"hoi210092r16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/096228029200100106","article-title":"Correspondence analysis in medical research.","volume":"1","author":"Greenacre","year":"1992","journal-title":"Stat Methods Med Res"},{"issue":"15","key":"hoi210092r17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.116.023463","article-title":"Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up.","volume":"135","author":"Narayan","year":"2017","journal-title":"Circulation"},{"issue":"30","key":"hoi210092r18","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1200\/JCO.2018.77.9736","article-title":"Risk-imaging mismatch in cardiac imaging practices for women receiving systemic therapy for early-stage breast cancer: a population-based cohort study.","volume":"36","author":"Thavendiranathan","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1 Pt 2","key":"hoi210092r19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcmg.2019.07.018","article-title":"Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy.","volume":"13","author":"Upshaw","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"hoi210092r20","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/cncr.32149","article-title":"Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy.","volume":"125","author":"Demissei","year":"2019","journal-title":"Cancer"},{"issue":"12","key":"hoi210092r21","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1001\/jamaoncol.2020.4749","article-title":"Early trastuzumab interruption and recurrence-free survival in ERBB2-positive breast cancer.","volume":"6","author":"Copeland-Halperin","year":"2020","journal-title":"JAMA Oncol"},{"issue":"3","key":"hoi210092r22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3747\/co.24.3349","article-title":"Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population.","volume":"24","author":"Rushton","year":"2017","journal-title":"Curr Oncol"},{"issue":"21","key":"hoi210092r23","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","article-title":"Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging.","volume":"28","author":"Walker","year":"2010","journal-title":"J Clin Oncol"},{"issue":"23","key":"hoi210092r24","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.","volume":"30","author":"Armstrong","year":"2012","journal-title":"J Clin Oncol"},{"issue":"20","key":"hoi210092r25","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.jacc.2012.01.037","article-title":"Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis.","volume":"59","author":"Dorosz","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi210092r26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/heartjnl-2019-316297","article-title":"Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.","volume":"106","author":"Lambert","year":"2020","journal-title":"Heart"},{"issue":"1","key":"hoi210092r27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"hoi210092r28","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1200\/JCO.2009.27.3615","article-title":"Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.","volume":"28","author":"Cardinale","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"hoi210092r29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jacc.2013.10.061","article-title":"Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.","volume":"63","author":"Ky","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi210092r30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamacardio.2019.2952","article-title":"Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: a systematic review and meta-analysis.","volume":"4","author":"Oikonomou","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"9","key":"hoi210092r31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1373\/clinchem.2015.241232","article-title":"Longitudinal changes in multiple biomarkers are associated with cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab.","volume":"61","author":"Putt","year":"2015","journal-title":"Clin Chem"},{"issue":"10","key":"hoi210092r32","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jcmg.2015.11.024","article-title":"Noninvasive measures of ventricular-arterial coupling and circumferential strain predict cancer therapeutics-related cardiac dysfunction.","volume":"9","author":"Narayan","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"hoi210092r33","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jcmg.2018.01.015","article-title":"Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction.","volume":"11","author":"Zhang","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"hoi210092r34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","article-title":"Strain-guided management of potentially cardiotoxic cancer therapy.","volume":"77","author":"Thavendiranathan","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi210092r35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ejhf.v22.2","article-title":"Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis.","volume":"22","author":"Michel","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"hoi210092r36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamacardio.2019.5586","article-title":"Long-term cardiopulmonary consequences of treatment-induced cardiotoxicity in survivors of erbb2-positive breast cancer.","volume":"5","author":"Yu","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"hoi210092r37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.","volume":"15","author":"Negishi","year":"2014","journal-title":"European heart journal cardiovascular Imaging"},{"issue":"12","key":"hoi210092r38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ehjci\/jez194","article-title":"Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction.","volume":"20","author":"Santoro","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"hoi210092r11","volume-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2012","edition":"2nd Edition"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2788571\/jamacardiology_esmaeilzadeh_2022_oi_210092_1646769437.25778.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T02:03:22Z","timestamp":1700186602000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2788571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2021.5881","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}